- D47.02 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM D47.02 became effective on October 1, 2022.
- This is the American ICD-10-CM version of D47.02 – other international versions of ICD-10 D47.02 may differ.
ICD-10-CM D47.02 is grouped within Diagnostic Related Group(s):
- 820 Lymphoma and leukemia with major o. R. Procedures with mcc
- 821 Lymphoma and leukemia with major o. R. Procedures with cc
- 822 Lymphoma and leukemia with major o. R. Procedures without cc/mcc
- 823 Lymphoma and non-acute leukemia with other procedures with mcc
- 824 Lymphoma and non-acute leukemia with other procedures with cc
- 825 Lymphoma and non-acute leukemia with other procedures without cc/mcc
- 840 Lymphoma and non-acute leukemia with mcc
- 841 Lymphoma and non-acute leukemia with cc
- 842 Lymphoma and non-acute leukemia without cc/mcc
Applicable To
- Indolent systemic mastocytosis
- Isolated bone marrow mastocytosis
- Smoldering systemic mastocytosis
- Systemic mastocytosis, with an associated hematological non-mast cell lineage disease (SM-AHNMD)
Type 1 Excludes
- aggressive systemic mastocytosis (C96.21)
- mast cell leukemia (C94.3-)
Code History
- 2018 (effective 10/1/2017): New code
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to D47.02:
- systemic tissue mast cell > Disease, diseased
- disease, systemic tissue > Mast cell
- indolent systemic > Mastocytosis D47.09
- isolated bone marrow > Mastocytosis D47.09
- systemic (indolent) (smoldering) > Mastocytosis D47.09
- with an associated hematological non-mast cell lineage disease (SM-AHNMD) > systemic (indolent) (smoldering) D47.02